Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.

Jamshed, Muhammad Babar

Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. [electronic resource] - American journal of physiology. Gastrointestinal and liver physiology 01 2020 - G109-G119 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1522-1547

10.1152/ajpgi.00130.2019 doi


Anaplastic Lymphoma Kinase--antagonists & inhibitors
Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Autophagy--drug effects
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Cell Size--drug effects
Deoxycytidine--analogs & derivatives
Drug Resistance, Neoplasm
Extracellular Signal-Regulated MAP Kinases--metabolism
Humans
Male
Mice, Inbred BALB C
Mice, Nude
Pancreatic Neoplasms--drug therapy
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins c-akt--metabolism
Pyrimidines--pharmacology
STAT3 Transcription Factor--metabolism
Signal Transduction
Sulfones--pharmacology
Xenograft Model Antitumor Assays
Gemcitabine